日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Protein kinase R regulates pancreatic ductal adenocarcinoma progression by modulating the cell cycle via GADD45A.

蛋白激酶 R 通过 GADD45A 调节细胞周期,从而调控胰腺导管腺癌的进展

Numata Yuki, Koizumi Mitsuhito, Watanabe Takao, Yoshida Osamu, Tokumoto Yoshio, Marui Kaori, Ishikawa Sho, Kokubu Masahito, Okujima Yusuke, Imamura Yoshiki, Miyake Teruki, Kumagi Teru, Hiasa Yoichi

Pancreatic Pseudocyst after Fully Covered Self-expandable Metallic Stent Placement

全覆膜自膨式金属支架置入术后胰腺假性囊肿

Koizumi, Mitsuhito; Ishikawa, Sho; Marui, Kaori; Kokubu, Masahito; Okujima, Yusuke; Numata, Yuki; Imamura, Yoshiki; Kumagi, Teru; Hiasa, Yoichi

Clinical Outcomes of S-1 Monotherapy and Modified FOLFIRINOX Therapy after Gemcitabine plus Nab-paclitaxel Therapy in Unresectable Pancreatic Cancer

吉西他滨联合白蛋白紫杉醇治疗后,S-1单药治疗和改良FOLFIRINOX方案治疗不可切除胰腺癌的临床结果

Hino, Kaori; Nishina, Tomohiro; Numata, Yuuki; Asagi, Akinori; Inoue, Tomonori; Yoshimatsu, Megumi; Sakaguchi, Chihiro; Nakasya, Akio; Nishide, Norifumi; Kajiwara, Takeshi; Terao, Takashi; Nadano, Seijin; Marui, Kaori; Okujima, Yusuke; Kokubu, Masahito; Imamura, Yoshiki; Kanemitsu, Kozue; Koizumi, Mitsuhito; Kumagi, Teru; Hiasa, Yoichi; Hyodo, Ichinosuke

Relation of Reduction of Antibodies against Hepatitis B Virus to Hepatocellular Carcinoma Recurrence in the Patients with Resolved Hepatitis B Virus Infection Following Direct-acting Antiviral Therapy for Hepatitis C Virus Infection

乙型肝炎病毒抗体降低与丙型肝炎病毒感染直接抗病毒治疗后乙型肝炎病毒感染清除患者肝细胞癌复发的关系

Joko, Kouji; Mashiba, Toshie; Ochi, Hironori; Yano, Ryo; Sato, Kaori; Okujima, Yusuke; Aono, Michiko; Azemoto, Nobuaki; Takechi, Shunji; Yokota, Tomoyuki; Jinoka, Ryosuke; Moriyama, Yasunori; Nishiyama, Masataka